home / stock / otlc / otlc news

OTLC News and Press, Oncotelic Therapeutics Inc From 05/24/22

Stock Information
Company Name: Oncotelic Therapeutics Inc
Stock Symbol: OTLC
Market: OTC
Website: oncotelic.com
Menu
OTLC OTLC Quote OTLC Short OTLC News OTLC Articles OTLC Message Board
Get OTLC Alerts

News, Short Squeeze, Breakout and More Instantly...
OTLC - Mateon Therapeutics reports Q1 results

Mateon Therapeutics press release (OTCQB:OTLC): Q1 net loss of $5.09M. For further details see: Mateon Therapeutics reports Q1 results

OTLC - ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 2021, PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE

AGOURA HILLS, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” , “ We ” or the “ Company ”) ( OTCQB: OTLC ) today announced financial results for...

OTLC - Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention

AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) ( OTCQB:OTLC ), developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today anno...

OTLC - ONCOTELIC ANNOUNCES US PATENT GRANT FOR CA4P AND OXI4503 COMBINATION WITH CHECKPOINT INHIBITORS

AGOURA HILLS, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), is pleased to announce the grant of patent application no. 15/753,882 entitled “USE OF VDAS TO ENHANCE IMMUNOMODULATING...
OTLC - Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer

AGOURA HILLS, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB :OTLC ), today announced the appointment of Dr. Seymour Fein as its Chief Regulatory Officer. Dr. Fein will guide the company...

OTLC - Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer

AGOURA HILLS, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” or the “Company” or “We” ) (OTCQB :OTLC ), today announced the appointment of Dr. Fatih Uckun as its Chief Medical Off...

OTLC - ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE

AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” , “ We ” or the “ Company ”) (OTCQB: OTLC ) today announced financial results for the fu...
OTLC - This Little Known Cancer Play has been Crushing the Market (ADGI, OTLC, DVAX, PACB, SAVA, NVAX, IMGN, BNTX)

Volatility remains the dominant factor across the equities market, with interest rates rising and growth stocks well underwater so far in 2022. Ground zero for this correction is among “long duration assets”, which includes growth stocks with big hypothetical cash flows down the...

OTLC - Letter to Oncotelic Shareholders on the Recently Completed Joint Venture Transaction with Dragon Overseas Capital Limited

AGOURA HILLS, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” or the “Company”) (OTCQB :OTLC ), issued the following shareholder letter today. Dear Fellow Shareholders, We would like to ...

OTLC - Oncotelic and Dragon Overseas Capital Limited Completed Joint Venture Transaction

AGOURA HILLS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) ( OTCQB:OTLC ), today announced the formation of a Joint Venture (“JV”) with Dragon Overseas Capital Limited (ȁ...
Previous 10 Next 10